CD4 and graft versus host disease: In GVHD models, ATRA promotes CD4+ Tregs generation to effectively alleviate GVHD but is unfavorable for CD8+ Tregs (78), which in turn indicates a differential response to ATRA by CD4+ and CD8+ Tregs and suggesting this possibility in vivo.